Sign In
Share

Recombivax-HB (Recombivax-HB)

All Clinical Trials

Common TitleSustaining Protection Against Hepatitis B From Infancy to Adulthood Non-Industry
Official Title Sustaining Protection Against Hepatitis B From Infancy to Adulthood: Assessing the Case for a Booster Dose in Adolescence
Phase Phase IV
ClinicalTrials.gov NCT02169674
Treatments
Recombivax-HB

Recombivax-HB

Tradename:Recombivax-HBClass:Vaccines (HBV)
Funding
Non-IndustryUniversity of British Columbia and Canadian Institutes of Health Research (CIHR)
References
  • Pinto M, Dawar M, Krajden M, Naus M, Scheifele DW. Will Infant Hepatitis B Vaccination Protect Into Adulthood?: Extended Canadian Experience After a 2-, 4- and 6-month Immunization Schedule. Pediatr Infect Dis J. 2017;36:609-615.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.